|
Secondary prevention
Citations 181-190 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Correspondence
Letter by Williams and Tabas Regarding Article "Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses"
- Kevin Jon Williams and Ira Tabas
Circulation 2006;113:e782, doi:10.1161/CIRCULATIONAHA.105.606962
[Full text]
- New Drugs and Technologies
Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular Conditions
- Bernard R. Chaitman
Circulation 2006;113:2462-2472, doi:10.1161/CIRCULATIONAHA.105.597500
[Full text]
- Epidemiology
Secular Trends in Deaths From Cardiovascular Diseases: A 25-Year Community Study
- Yariv Gerber, Steven J. Jacobsen, Robert L. Frye, Susan A. Weston, Jill M. Killian, and Véronique L. Roger
Circulation 2006;113:2285-2292; published online before print as doi:10.1161/CIRCULATIONAHA.105.590463
[Abstract]
[Full text]
- AHA/ACC Guideline
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute
- Sidney C. Smith, Jr, Jerilyn Allen, Steven N. Blair, Robert O. Bonow, Lawrence M. Brass, Gregg C. Fonarow, Scott M. Grundy, Loren Hiratzka, Daniel Jones, Harlan M. Krumholz, Lori Mosca, Richard C. Pasternak, Thomas Pearson, Marc A. Pfeffer, and Kathryn A. Taubert
Circulation 2006;113:2363-2372, doi:10.1161/CIRCULATIONAHA.106.174516
[Full text]
- Articles
Secular Trends in Deaths From Cardiovascular Diseases. A 25-Year Community Study
- Yariv Gerber, Steven J. Jacobsen, Robert L. Frye, Susan A. Weston, Jill M. Killian, and Véronique L. Roger
Circulation published May 8, 2006, doi:10.1161/CIRCULATIONAHA.105.590463
[Abstract]
- Coronary Heart Disease
Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
- James D. Otvos, Dorothea Collins, David S. Freedman, Irina Shalaurova, Ernst J. Schaefer, Judith R. McNamara, Hanna E. Bloomfield, and Sander J. Robins
Circulation 2006;113:1556-1563; published online before print as doi:10.1161/CIRCULATIONAHA.105.565135
[Abstract]
[Full text]
- Editorials
Direct Comparison of the A to Z and PROVE IT Trials: A Second Chance to Gain a First Impression
- B. Greg Brown
Circulation 2006;113:1382-1384, doi:10.1161/CIRCULATIONAHA.106.612374
[Full text]
- Coronary Heart Disease
A Tale of Two Trials: A Comparison of the Post–Acute Coronary Syndrome Lipid-Lowering Trials A to Z and PROVE IT–TIMI 22
- Stephen D. Wiviott, James A. de Lemos, Christopher P. Cannon, Michael Blazing, Sabina A. Murphy, Carolyn H. McCabe, Robert Califf, and Eugene Braunwald
Circulation 2006;113:1406-1414; published online before print as doi:10.1161/CIRCULATIONAHA.105.586347
[Abstract]
[Full text]
- Articles
A Tale of Two Trials. A Comparison of the Post-Acute Coronary Syndrome Lipid-Lowering Trials A to Z and PROVE IT-TIMI 22
- Stephen D. Wiviott, James A. de Lemos, Christopher P. Cannon, Michael Blazing, Sabina A. Murphy, Carolyn H. McCabe, Robert Califf, and Eugene Braunwald
Circulation published March 13, 2006, doi:10.1161/CIRCULATIONAHA.105.586347
[Abstract]
- Articles
Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
- James D. Otvos, Dorothea Collins, David S. Freedman, Irina Shalaurova, Ernst J. Schaefer, Judith R. McNamara, Hanna E. Bloomfield, and Sander J. Robins
Circulation published March 13, 2006, doi:10.1161/CIRCULATIONAHA.105.565135
[Abstract]
|
|
